Skip to main content

memo - Magazine of European Medical Oncology

Ausgabe 3/2012

Inhalt (20 Artikel)

News from the Neuro-Oncology front

  • editorial

Silvia Hofer, Christine Marosi

ASH 2011—Hodgkin’s disease and the high grade lymphomas

  • special report

Wolfgang Willenbacher, Ella Willenbacher

Treating T-cell lymphoma: is there a light at the end of the tunnel?

  • short review

Georg Hopfinger, Olaf Merkel, Thomas Melchardt, Richard Greil

Brief update on recent developments in CML

  • short review

Stefan Schmidt

New developments in MDS

  • short review

Michael Pfeilstöcker, Reinhard Stauder

ASH 2011—current developments in AML

  • short review

Johannes Clausen

Paraneoplastic neurologic disorders: a brief overview

  • short review

Myrna R. Rosenfeld, Josep Dalmau

Clinically useful biomarkers in neurooncology

  • short review

Matthias Preusser

Carcinomatous meningitis

  • short review

Marc C. Chamberlain

Advanced neuroimaging techniques for diagnosis and treatment evaluation in neuro-oncology

  • short review

Bernhard Schuknecht, Krisztina Baráth, Silvia Hofer

Current treatment of low grade gliomas

  • Open Access
  • review

Martin J. van den Bent, Tom J. Snijders, Jacoline E. C. Bromberg

Update on molecular and genetic alterations in adult medulloblastoma

  • Open Access
  • short review

Marcel Kool, Andrey Korshunov, Stefan M. Pfister

The End-of-Life in patients with glioma and their families

  • short review

Christine Marosi, Birgit Flechl, Stefan Oberndorfer

New drugs for head and neck cancer

  • short review

József Dudás, Heinz Zwierzina, Georg Mathias Sprinzl

Sorafenib in thyroid cancer—a retrospective case series

  • case report

Gabriele Gamerith, Andreas Pircher, Arno Amann, Katharina Cima, Klaus Gasser, Markus Lenzhofer, Peter Lind, Evelyne Bareck, Ewald Wöll, Wolfgang Hilbe